DISCLAIMER — Not financial advice. Educational content only, not an offer or solicitation to buy or sell any security. Biotech and small/mid-cap stocks are highly speculative and volatile and can result in a partial or total loss of capital. Do your own research and consult a licensed advisor where appropriate. / Contenuti a solo scopo informativo e didattico, non costituiscono consulenza finanziaria né offerta o sollecitazione al pubblico risparmio ai sensi delle normative CONSOB e SEC. Le azioni biotech e le small/mid cap sono strumenti altamente speculativi e volatili e possono comportare la perdita parziale o totale del capitale investito. Si raccomanda di effettuare sempre le proprie ricerche e, se necessario, di rivolgersi a un consulente abilitato.

Merlintrader Trading Pub
Biotech catalyst news and analysis. FDA PDUFA tracker

Merlintrader Trading Pub
Biotech catalyst news and analysis. FDA PDUFA tracker
Category Intraday
Intraday Charts and Alerts
Actelis Networks ( $ASNS ) – Cyber-Hardened Networking For Critical Infrastructure In 2026

Ultra-microcap deep dive on Actelis Networks after a series of transportation, utility and carrier orders, reverse split and financing moves. Focus on the core technology, recent contracts, balance sheet stress and the asymmetry between operational progress and capital structure risk.
ParaZero ($PRZO) DefendAir intercepts a hostile drone at ~70 mph

The company says this is its first successful net-based interception at that speed, positioning DefendAir for “on-the-move” protection against fast FPV-style threats and other tactical drones.
Jiade Ltd ($JDZG)

Jiade is a micro-cap education-support company listed on Nasdaq, best known for providing tutoring and training services for adult and vocational education in China. A strategic cooperation with a South Korea–based AI education brand adds an international angle, but the story still sits at the intersection of cross-border ambitions, regulatory risk and the harsh math of small-cap liquidity.
CYN Cyngn Inc

Cyngn (ticker CYN) sits in a corner of the market that many traders only notice when the tape goes vertical: micro-cap industrial autonomy. This is not a classical biotech binary, not a cash-generating SaaS giant, and definitely not a clean “AI story” with nine-figure revenues. It is a company trying to turn a fairly sophisticated autonomy stack into a repeatable, contract-driven business in forklifts, tuggers and other industrial vehicles – while burning real money and living under the constant threat of dilution.
VIVS VivoSim Labs Inc

Real-time news feeds (RTTNews, MarketScreener, StockTitan, QuiverQuant) and broker dashboards show VIVS up roughly +70–100% in pre-market trading on 30 January 2026, with pre-market prices around 3.0 USD and, in some snapshots, higher peaks depending on the exact timestamp. Versus a previous close of 1.70 USD, this is a classic microcap “gap & squeeze” setting, driven by a mix of genuine news and positioning on a very small float.
JFBR Jeffs Brands Ltd

Jeffs’ Brands Ltd is a tiny Israeli micro-cap originally built around a data-driven Amazon FBA portfolio. That legacy business is still there: roughly $13.7M revenue in FY2024 against a net loss of about $7.8M, with a very small equity value and high operating leverage. The last twelve months have been brutal for long-term holders, with a price trajectory closer to a ski slope than a growth story.
Market backdrop – Christmas Eve mood

Wall Street comes into Christmas Eve with the S&P 500 at fresh record highs after several strong sessions driven mainly by mega-cap tech. Today’s session is shortened, volumes are thin and the mood is a mix of “Santa Claus rally” and “better not break anything before the holidays”.
Premarket Update dec 22 – Tech Strength, Positive Futures and a Focus on Biotech Catalysts

Christmas week: lower liquidity, but often faster and more technical moves. Below you’ll find market movers, Europe/commodities, and a “Biotech Special” built on calendar catalysts (RVPH, ARGX, AARD, plus technical notes on ZLAB and HALO).
BCRX BioCryst

(BCRX) Update: FDA Expands ORLADEYO Approval to Younger Children | Merlintrader trading Blog
DAL Delta Air Lines

Delta today looks like the carrier you used to book for demanding but pragmatic business clients. Strong hub positioning in Atlanta, a wide global network and a product built around a rich mix of premium cabins and corporate traffic.
VERI Veritone

Veritone is a small-cap AI/software company that has struggled for several years with dilution, weak fundamentals, and high volatility. Today’s ~12% move appears more like a speculative rebound than a structural change
KALA Bio Caution risk 100%
KALA Bio was a clinical-stage biotech developing KPI-012, a mesenchymal stem cell secretome (MSC-S) therapy for Persistent Corneal Epithelial Defect (PCED), an orphan eye disease with ~100,000 US patients and no FDA-approved treatments.
SYM Symbotic Inc

Symbotic surges +35% post-earnings; valuation tightens as growth investors price in upside
OSCR Oscar Health
oscr-aca-catalyst-report-nov24-2025.html OSCR Breaking News | Oscar Health | Merlintrader ?? ?? OSCR BREAKING CATALYST ACA SUBSIDY EXTENSION November 24, 2025 | Political Healthcare Policy Breakthrough OSCR CATALYST ACUTO ESTENSIONE SUSSIDI ACA 24 Novembre 2025 | Breakthrough Politica Healthcare Executive Summary…
NVRI Enviri Corporation

Enviri Corporation Announces Sale of Clean Earth to Veolia for $3.04 Billion and Taxable Spin-Off of Harsco Environmental and Rail Businesses ("New Enviri") to Shareholders
MNDR Mobile-health Network Solutions

Mobile-health Network Solutions (MNDR) announced a non-binding MOU on November 19, 2025, to acquire two AI-optimized data centers in Malaysia valued up to $120 million.
STEC E-Commerce Revolution

Intraday Move premarket gainer